Position in INCY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$48,578,500
-$16,709,249 QoQ
Shares Held
428,533
-38.2% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#65
of 849 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. INCY ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
This page
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,578,500 | 428,533 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $65,287,749 | 693,665 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $67,586,631 | 684,283 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $58,733,130 | 692,526 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $47,719,304 | 700,724 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,411,586 | 337,103 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $21,149,648 | 306,206 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $21,079,356 | 318,901 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,018,457 | 363,221 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $22,014,404 | 386,421 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $37,915,867 | 603,852 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $33,620,522 | 581,972 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $34,513,143 | 554,428 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $39,858,856 | 551,527 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $43,578,258 | 542,558 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $36,131,808 | 542,194 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $41,986,111 | 552,667 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $39,613,266 | 498,782 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $35,004,900 | 476,906 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $30,064,425 | 437,110 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $35,360,680 | 420,310 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $33,744,360 | 415,213 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $36,799,846 | 423,084 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $37,421,221 | 416,996 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $43,456,548 | 417,972 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $28,382,629 | 387,582 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||